Heidelberg, Germany

Thomas Schlüter

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Thomas Schlüter: Innovations in Ophthalmic Treatments

Introduction

Thomas Schlüter, an inventive mind located in Heidelberg, Germany, has made significant contributions to the field of ophthalmology. With an impressive portfolio of four patents, Schlüter focuses on developing innovative treatments for ocular conditions, particularly dry eye disease.

Latest Patents

Schlüter's latest inventions showcase his dedication to improving eye care. His first significant patent details an ophthalmic composition for the treatment of dry eye disease, which includes about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane. This invention not only provides effective topical treatment methods but also encompasses kits containing the formulated compositions.

Another noteworthy patent involves ophthalmic compositions comprising semifluorinated alkanes aimed at treating keratoconjunctivitis sicca and Meibomian gland dysfunction. This technology emphasizes methods for enriching ophthalmic tissue with the semifluorinated alkane, as well as providing strategies for a delayed release of the compound, enhancing its efficacy in treatment.

Career Highlights

Over the years, Thomas Schlüter has collaborated with esteemed companies such as Novaliq GmbH and Phenex Pharmaceuticals AG. His work within these organizations has fueled advancements in ophthalmic therapies, positioning him as a knowledgeable figure in the pharmaceutical landscape.

Collaborations

Throughout his career, Schlüter has exchanged ideas and knowledge with skilled professionals, including notable coworkers Sonja Krösser and Chiara Silvana Leo. Their combined efforts contribute to the growth and innovation within the ophthalmology sector, allowing for a collaborative approach to developing new treatments.

Conclusion

Thomas Schlüter is a remarkable inventor whose insights and inventions continue to advance the field of eye care. His patents emphasize the importance of innovative solutions to common ocular conditions, showcasing his expertise and commitment to improving patient outcomes. With a career marked by groundbreaking work and meaningful collaborations, Schlüter stands at the forefront of ophthalmic innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…